Global Opiate Antagonist Market Growth (Status and Outlook) 2022-2028
The global market for Opiate Antagonist is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Opiate Antagonist market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Opiate Antagonist market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Opiate Antagonist market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Opiate Antagonist market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Opiate Antagonist players cover Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Cardinal Health and Baxter Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Opiate Antagonist market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Opiate Antagonist market, with both quantitative and qualitative data, to help readers understand how the Opiate Antagonist market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Opiate Antagonist market and forecasts the market size by Type (0.4 mg/ml, 1 mg/ml and 2 mg/ml), by Application (Hospital, Clinics, Pharmacy and Home), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
0.4 mg/ml
1 mg/ml
2 mg/ml
Segmentation by application
Hospital
Clinics
Pharmacy
Home
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Pfizer
Sun Pharmaceutical Industries
Teva Pharmaceuticals
Cardinal Health
Baxter Pharmaceutical
Adapt Pharmaceuticals
Dr. Reddy's Laboratories
GIV Repack
Intl Medication Systems
Kaleo Pharma
Mylan Institutional
Perrigo Pharmaceuticals
AuroMedics Pharma
Somerset Pharma
Akorn
Alkermes
Chapter Introduction
Chapter 1: Scope of Opiate Antagonist, Research Methodology, etc.
Chapter 2: Executive Summary, global Opiate Antagonist market size and CAGR, Opiate Antagonist market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Opiate Antagonist revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Opiate Antagonist revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Opiate Antagonist market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer, Sun Pharmaceutical Industries, Teva Pharmaceuticals, Cardinal Health, Baxter Pharmaceutical, Adapt Pharmaceuticals, Dr. Reddy's Laboratories, GIV Repack and Intl Medication Systems, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opiate Antagonist Market Size 2017-2028
2.1.2 Opiate Antagonist Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Opiate Antagonist Segment by Type
2.2.1 0.4 mg/ml
2.2.2 1 mg/ml
2.2.3 2 mg/ml
2.3 Opiate Antagonist Market Size by Type
2.3.1 Opiate Antagonist Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Opiate Antagonist Market Size Market Share by Type (2017-2022)
2.4 Opiate Antagonist Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Pharmacy
2.4.4 Home
2.4.5 Others
2.5 Opiate Antagonist Market Size by Application
2.5.1 Opiate Antagonist Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Opiate Antagonist Market Size Market Share by Application (2017-2022)
3 Opiate Antagonist Market Size by Player
3.1 Opiate Antagonist Market Size Market Share by Players
3.1.1 Global Opiate Antagonist Revenue by Players (2020-2022)
3.1.2 Global Opiate Antagonist Revenue Market Share by Players (2020-2022)
3.2 Global Opiate Antagonist Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Opiate Antagonist by Regions
4.1 Opiate Antagonist Market Size by Regions (2017-2022)
4.2 Americas Opiate Antagonist Market Size Growth (2017-2022)
4.3 APAC Opiate Antagonist Market Size Growth (2017-2022)
4.4 Europe Opiate Antagonist Market Size Growth (2017-2022)
4.5 Middle East & Africa Opiate Antagonist Market Size Growth (2017-2022)
5 Americas
5.1 Americas Opiate Antagonist Market Size by Country (2017-2022)
5.2 Americas Opiate Antagonist Market Size by Type (2017-2022)
5.3 Americas Opiate Antagonist Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opiate Antagonist Market Size by Region (2017-2022)
6.2 APAC Opiate Antagonist Market Size by Type (2017-2022)
6.3 APAC Opiate Antagonist Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Opiate Antagonist by Country (2017-2022)
7.2 Europe Opiate Antagonist Market Size by Type (2017-2022)
7.3 Europe Opiate Antagonist Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Opiate Antagonist by Region (2017-2022)
8.2 Middle East & Africa Opiate Antagonist Market Size by Type (2017-2022)
8.3 Middle East & Africa Opiate Antagonist Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Opiate Antagonist Market Forecast
10.1 Global Opiate Antagonist Forecast by Regions (2023-2028)
10.1.1 Global Opiate Antagonist Forecast by Regions (2023-2028)
10.1.2 Americas Opiate Antagonist Forecast
10.1.3 APAC Opiate Antagonist Forecast
10.1.4 Europe Opiate Antagonist Forecast
10.1.5 Middle East & Africa Opiate Antagonist Forecast
10.2 Americas Opiate Antagonist Forecast by Country (2023-2028)
10.2.1 United States Opiate Antagonist Market Forecast
10.2.2 Canada Opiate Antagonist Market Forecast
10.2.3 Mexico Opiate Antagonist Market Forecast
10.2.4 Brazil Opiate Antagonist Market Forecast
10.3 APAC Opiate Antagonist Forecast by Region (2023-2028)
10.3.1 China Opiate Antagonist Market Forecast
10.3.2 Japan Opiate Antagonist Market Forecast
10.3.3 Korea Opiate Antagonist Market Forecast
10.3.4 Southeast Asia Opiate Antagonist Market Forecast
10.3.5 India Opiate Antagonist Market Forecast
10.3.6 Australia Opiate Antagonist Market Forecast
10.4 Europe Opiate Antagonist Forecast by Country (2023-2028)
10.4.1 Germany Opiate Antagonist Market Forecast
10.4.2 France Opiate Antagonist Market Forecast
10.4.3 UK Opiate Antagonist Market Forecast
10.4.4 Italy Opiate Antagonist Market Forecast
10.4.5 Russia Opiate Antagonist Market Forecast
10.5 Middle East & Africa Opiate Antagonist Forecast by Region (2023-2028)
10.5.1 Egypt Opiate Antagonist Market Forecast
10.5.2 South Africa Opiate Antagonist Market Forecast
10.5.3 Israel Opiate Antagonist Market Forecast
10.5.4 Turkey Opiate Antagonist Market Forecast
10.5.5 GCC Countries Opiate Antagonist Market Forecast
10.6 Global Opiate Antagonist Forecast by Type (2023-2028)
10.7 Global Opiate Antagonist Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Opiate Antagonist Product Offered
11.1.3 Pfizer Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Sun Pharmaceutical Industries
11.2.1 Sun Pharmaceutical Industries Company Information
11.2.2 Sun Pharmaceutical Industries Opiate Antagonist Product Offered
11.2.3 Sun Pharmaceutical Industries Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sun Pharmaceutical Industries Main Business Overview
11.2.5 Sun Pharmaceutical Industries Latest Developments
11.3 Teva Pharmaceuticals
11.3.1 Teva Pharmaceuticals Company Information
11.3.2 Teva Pharmaceuticals Opiate Antagonist Product Offered
11.3.3 Teva Pharmaceuticals Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Teva Pharmaceuticals Main Business Overview
11.3.5 Teva Pharmaceuticals Latest Developments
11.4 Cardinal Health
11.4.1 Cardinal Health Company Information
11.4.2 Cardinal Health Opiate Antagonist Product Offered
11.4.3 Cardinal Health Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Cardinal Health Main Business Overview
11.4.5 Cardinal Health Latest Developments
11.5 Baxter Pharmaceutical
11.5.1 Baxter Pharmaceutical Company Information
11.5.2 Baxter Pharmaceutical Opiate Antagonist Product Offered
11.5.3 Baxter Pharmaceutical Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Baxter Pharmaceutical Main Business Overview
11.5.5 Baxter Pharmaceutical Latest Developments
11.6 Adapt Pharmaceuticals
11.6.1 Adapt Pharmaceuticals Company Information
11.6.2 Adapt Pharmaceuticals Opiate Antagonist Product Offered
11.6.3 Adapt Pharmaceuticals Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Adapt Pharmaceuticals Main Business Overview
11.6.5 Adapt Pharmaceuticals Latest Developments
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Information
11.7.2 Dr. Reddy's Laboratories Opiate Antagonist Product Offered
11.7.3 Dr. Reddy's Laboratories Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Dr. Reddy's Laboratories Main Business Overview
11.7.5 Dr. Reddy's Laboratories Latest Developments
11.8 GIV Repack
11.8.1 GIV Repack Company Information
11.8.2 GIV Repack Opiate Antagonist Product Offered
11.8.3 GIV Repack Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 GIV Repack Main Business Overview
11.8.5 GIV Repack Latest Developments
11.9 Intl Medication Systems
11.9.1 Intl Medication Systems Company Information
11.9.2 Intl Medication Systems Opiate Antagonist Product Offered
11.9.3 Intl Medication Systems Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Intl Medication Systems Main Business Overview
11.9.5 Intl Medication Systems Latest Developments
11.10 Kaleo Pharma
11.10.1 Kaleo Pharma Company Information
11.10.2 Kaleo Pharma Opiate Antagonist Product Offered
11.10.3 Kaleo Pharma Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Kaleo Pharma Main Business Overview
11.10.5 Kaleo Pharma Latest Developments
11.11 Mylan Institutional
11.11.1 Mylan Institutional Company Information
11.11.2 Mylan Institutional Opiate Antagonist Product Offered
11.11.3 Mylan Institutional Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Mylan Institutional Main Business Overview
11.11.5 Mylan Institutional Latest Developments
11.12 Perrigo Pharmaceuticals
11.12.1 Perrigo Pharmaceuticals Company Information
11.12.2 Perrigo Pharmaceuticals Opiate Antagonist Product Offered
11.12.3 Perrigo Pharmaceuticals Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Perrigo Pharmaceuticals Main Business Overview
11.12.5 Perrigo Pharmaceuticals Latest Developments
11.13 AuroMedics Pharma
11.13.1 AuroMedics Pharma Company Information
11.13.2 AuroMedics Pharma Opiate Antagonist Product Offered
11.13.3 AuroMedics Pharma Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 AuroMedics Pharma Main Business Overview
11.13.5 AuroMedics Pharma Latest Developments
11.14 Somerset Pharma
11.14.1 Somerset Pharma Company Information
11.14.2 Somerset Pharma Opiate Antagonist Product Offered
11.14.3 Somerset Pharma Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Somerset Pharma Main Business Overview
11.14.5 Somerset Pharma Latest Developments
11.15 Akorn
11.15.1 Akorn Company Information
11.15.2 Akorn Opiate Antagonist Product Offered
11.15.3 Akorn Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Akorn Main Business Overview
11.15.5 Akorn Latest Developments
11.16 Alkermes
11.16.1 Alkermes Company Information
11.16.2 Alkermes Opiate Antagonist Product Offered
11.16.3 Alkermes Opiate Antagonist Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Alkermes Main Business Overview
11.16.5 Alkermes Latest Developments
12 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Opiate Antagonist Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 0.4 mg/ml
Table 3. Major Players of 1 mg/ml
Table 4. Major Players of 2 mg/ml
Table 5. Opiate Antagonist Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Opiate Antagonist Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Opiate Antagonist Market Size Market Share by Type (2017-2022)
Table 8. Opiate Antagonist Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Opiate Antagonist Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Opiate Antagonist Market Size Market Share by Application (2017-2022)
Table 11. Global Opiate Antagonist Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Opiate Antagonist Revenue Market Share by Player (2020-2022)
Table 13. Opiate Antagonist Key Players Head office and Products Offered
Table 14. Opiate Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Opiate Antagonist Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Opiate Antagonist Market Size Market Share by Regions (2017-2022)
Table 19. Americas Opiate Antagonist Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Opiate Antagonist Market Size Market Share by Country (2017-2022)
Table 21. Americas Opiate Antagonist Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Opiate Antagonist Market Size Market Share by Type (2017-2022)
Table 23. Americas Opiate Antagonist Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Opiate Antagonist Market Size Market Share by Application (2017-2022)
Table 25. APAC Opiate Antagonist Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Opiate Antagonist Market Size Market Share by Region (2017-2022)
Table 27. APAC Opiate Antagonist Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Opiate Antagonist Market Size Market Share by Type (2017-2022)
Table 29. APAC Opiate Antagonist Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Opiate Antagonist Market Size Market Share by Application (2017-2022)
Table 31. Europe Opiate Antagonist Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Opiate Antagonist Market Size Market Share by Country (2017-2022)
Table 33. Europe Opiate Antagonist Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Opiate Antagonist Market Size Market Share by Type (2017-2022)
Table 35. Europe Opiate Antagonist Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Opiate Antagonist Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Opiate Antagonist Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Opiate Antagonist Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Opiate Antagonist Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Opiate Antagonist Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Opiate Antagonist Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Opiate Antagonist Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Opiate Antagonist
Table 44. Key Market Challenges & Risks of Opiate Antagonist
Table 45. Key Industry Trends of Opiate Antagonist
Table 46. Global Opiate Antagonist Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Opiate Antagonist Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Opiate Antagonist Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Opiate Antagonist Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Opiate Antagonist Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Opiate Antagonist Market Size Market Share Forecast by Application (2023-2028)
Table 52. Pfizer Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 53. Pfizer Opiate Antagonist Product Offered
Table 54. Pfizer Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Sun Pharmaceutical Industries Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 58. Sun Pharmaceutical Industries Opiate Antagonist Product Offered
Table 59. Sun Pharmaceutical Industries Main Business
Table 60. Sun Pharmaceutical Industries Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Sun Pharmaceutical Industries Latest Developments
Table 62. Teva Pharmaceuticals Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 63. Teva Pharmaceuticals Opiate Antagonist Product Offered
Table 64. Teva Pharmaceuticals Main Business
Table 65. Teva Pharmaceuticals Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Teva Pharmaceuticals Latest Developments
Table 67. Cardinal Health Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 68. Cardinal Health Opiate Antagonist Product Offered
Table 69. Cardinal Health Main Business
Table 70. Cardinal Health Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Cardinal Health Latest Developments
Table 72. Baxter Pharmaceutical Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 73. Baxter Pharmaceutical Opiate Antagonist Product Offered
Table 74. Baxter Pharmaceutical Main Business
Table 75. Baxter Pharmaceutical Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Baxter Pharmaceutical Latest Developments
Table 77. Adapt Pharmaceuticals Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 78. Adapt Pharmaceuticals Opiate Antagonist Product Offered
Table 79. Adapt Pharmaceuticals Main Business
Table 80. Adapt Pharmaceuticals Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Adapt Pharmaceuticals Latest Developments
Table 82. Dr. Reddy's Laboratories Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 83. Dr. Reddy's Laboratories Opiate Antagonist Product Offered
Table 84. Dr. Reddy's Laboratories Main Business
Table 85. Dr. Reddy's Laboratories Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Dr. Reddy's Laboratories Latest Developments
Table 87. GIV Repack Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 88. GIV Repack Opiate Antagonist Product Offered
Table 89. GIV Repack Main Business
Table 90. GIV Repack Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. GIV Repack Latest Developments
Table 92. Intl Medication Systems Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 93. Intl Medication Systems Opiate Antagonist Product Offered
Table 94. Intl Medication Systems Main Business
Table 95. Intl Medication Systems Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Intl Medication Systems Latest Developments
Table 97. Kaleo Pharma Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 98. Kaleo Pharma Opiate Antagonist Product Offered
Table 99. Kaleo Pharma Main Business
Table 100. Kaleo Pharma Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Kaleo Pharma Latest Developments
Table 102. Mylan Institutional Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 103. Mylan Institutional Opiate Antagonist Product Offered
Table 104. Mylan Institutional Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Mylan Institutional Main Business
Table 106. Mylan Institutional Latest Developments
Table 107. Perrigo Pharmaceuticals Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 108. Perrigo Pharmaceuticals Opiate Antagonist Product Offered
Table 109. Perrigo Pharmaceuticals Main Business
Table 110. Perrigo Pharmaceuticals Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. Perrigo Pharmaceuticals Latest Developments
Table 112. AuroMedics Pharma Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 113. AuroMedics Pharma Opiate Antagonist Product Offered
Table 114. AuroMedics Pharma Main Business
Table 115. AuroMedics Pharma Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. AuroMedics Pharma Latest Developments
Table 117. Somerset Pharma Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 118. Somerset Pharma Opiate Antagonist Product Offered
Table 119. Somerset Pharma Main Business
Table 120. Somerset Pharma Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Somerset Pharma Latest Developments
Table 122. Akorn Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 123. Akorn Opiate Antagonist Product Offered
Table 124. Akorn Main Business
Table 125. Akorn Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Akorn Latest Developments
Table 127. Alkermes Details, Company Type, Opiate Antagonist Area Served and Its Competitors
Table 128. Alkermes Opiate Antagonist Product Offered
Table 129. Alkermes Main Business
Table 130. Alkermes Opiate Antagonist Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Alkermes Latest Developments
List of Figures
List of Figures
Figure 1. Opiate Antagonist Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Opiate Antagonist Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Opiate Antagonist Market Size Market Share by Type in 2021
Figure 7. Opiate Antagonist in Hospital
Figure 8. Global Opiate Antagonist Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Opiate Antagonist in Clinics
Figure 10. Global Opiate Antagonist Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Opiate Antagonist in Pharmacy
Figure 12. Global Opiate Antagonist Market: Pharmacy (2017-2022) & ($ Millions)
Figure 13. Opiate Antagonist in Home
Figure 14. Global Opiate Antagonist Market: Home (2017-2022) & ($ Millions)
Figure 15. Opiate Antagonist in Others
Figure 16. Global Opiate Antagonist Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Opiate Antagonist Market Size Market Share by Application in 2021
Figure 18. Global Opiate Antagonist Revenue Market Share by Player in 2021
Figure 19. Global Opiate Antagonist Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Opiate Antagonist Market Size 2017-2022 ($ Millions)
Figure 21. APAC Opiate Antagonist Market Size 2017-2022 ($ Millions)
Figure 22. Europe Opiate Antagonist Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Opiate Antagonist Market Size 2017-2022 ($ Millions)
Figure 24. Americas Opiate Antagonist Value Market Share by Country in 2021
Figure 25. Americas Opiate Antagonist Consumption Market Share by Type in 2021
Figure 26. Americas Opiate Antagonist Market Size Market Share by Application in 2021
Figure 27. United States Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Opiate Antagonist Market Size Market Share by Region in 2021
Figure 32. APAC Opiate Antagonist Market Size Market Share by Application in 2021
Figure 33. China Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Opiate Antagonist Market Size Market Share by Country in 2021
Figure 40. Europe Opiate Antagonist Market Size Market Share by Type in 2021
Figure 41. Europe Opiate Antagonist Market Size Market Share by Application in 2021
Figure 42. Germany Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Opiate Antagonist Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Opiate Antagonist Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Opiate Antagonist Market Size Market Share by Application in 2021
Figure 50. Egypt Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Opiate Antagonist Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 56. APAC Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 57. Europe Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 59. United States Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 60. Canada Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 63. China Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 64. Japan Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 65. Korea Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 67. India Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 68. Australia Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 69. Germany Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 70. France Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 71. UK Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 72. Italy Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 73. Russia Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 74. Spain Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 77. Israel Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Opiate Antagonist Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Opiate Antagonist Market Size 2023-2028 ($ Millions)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets